retinoic acid, bromodeoxyuridine, and the Delta 205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation

Retinoic acid (RA), bromodeoxyuridine (BrdU), and the Delta 205 mutant polyoma middle T antigen affect the expression of a common ensemble of proteins in HL-60 human myeloblastic leukemia cells. Each of these agents is known to be able to prime HL-60 cells and accelerate subsequently induced myeloid...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	In vitro cellular & developmental biology. Animal 2004-07, Vol.40 (7), p.216-241
Hauptverfasser:	Yen, Andrew, Lin, David M, Lamkin, Thomas J, Varvayanis, Susi
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens, Polyomavirus Transforming - genetics Antigens, Polyomavirus Transforming - pharmacology Bromodeoxyuridine - pharmacology Cell Differentiation - genetics Gene Expression Regulation - drug effects HL-60 Cells Humans Mutation Polyomavirus Tretinoin - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!